1. Oncolytic Adenoviruses in Gastrointestinal Cancers
   Raquel Yokoda et al, 2018, Biomedicines CrossRef
2. Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
   Rohtesh S. Mehta et al, 2018, Frontiers in Immunology CrossRef
3. Natural killer cell homing and trafficking in tissues and tumors: from biology to application
   Guang he Ran et al, 2022, Signal Transduction and Targeted Therapy CrossRef
4. Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma
   Jack Hutcheson et al, 2014, Hepatology CrossRef
5. Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia
   Mariko Okamoto et al, 2016, Veterinary Research Communications CrossRef
6. Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
   Mubalake Abudoureyimu et al, 2019, Frontiers in Oncology CrossRef
7. Construction and application of adenoviral vectors
   Hongbo Zhang et al, 2023, Molecular Therapy - Nucleic Acids CrossRef
8. Oncolytic Immunotherapy for Treatment of Cancer
   A. Tsun et al, 2016, Progress in Cancer Immunotherapy CrossRef
9. Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs
   C Chen et al, 2014, Gene Therapy CrossRef
10. Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
    Yinghan Su et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
11. Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma
    Dandan Guo et al, 2023, Technology in Cancer Research & Treatment CrossRef
12. NK cells and solid tumors: therapeutic potential and persisting obstacles
    Le Tong et al, 2022, Molecular Cancer CrossRef
13. Evolution of oncolytic viruses: novel strategies for cancer treatment
    Matthew J Atherton et al, 2013, Immunotherapy CrossRef
14. Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma
    Adel H. Jebar et al, 2015, Journal of General Virology CrossRef
15. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls
    Mohan Babu Appaiahgari et al, 2015, Expert Opinion on Biological Therapy CrossRef
16. Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway
    Yang Wang et al, 2016, PLOS ONE CrossRef
17. Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses
    Shao-Chia Lu et al, 2022, Expert Opinion on Biological Therapy CrossRef
18. From Benchtop to Bedside: A Review of Oncolytic Virotherapy
    Audrey Choi et al, 2016, Biomedicines CrossRef
19. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
    Astha Malik et al, 2021, Frontiers in Oncology CrossRef
20. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
    Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef
21. Trial Watch:
    Jonathan Pol et al, 2014, OncoImmunology CrossRef
22. Trial Watch—Oncolytic viruses and cancer therapy
    Jonathan Pol et al, 2016, OncoImmunology CrossRef
23. Intratumoral IL-28B Gene Delivery Elicits Antitumor Effects by Remodeling of the Tumor Microenvironment in H22-Bearing Mice
    Zhi Li et al, 2022, Journal of Immunology Research CrossRef
24. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
    Jan Korbecki et al, 2020, International Journal of Molecular Sciences CrossRef